Jing Tian
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 16
- MicroRNA in disease regulation 10
- Physiology top 5%
- Molecular Biology top 10%
- Circular RNAs in diseases 8
- RNA Research and Splicing 7
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 5
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research 4
- Reproductive Medicine top 10%
-
- Magnetic Bearings and Levitation Dynamics 3
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Jing Tian
51 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 498
- Physiology 52
- Molecular Biology 751
- Clinical Biochemistry 54
- Reproductive Medicine 63
Countries citing papers authored by Jing Tian
This map shows the geographic impact of Jing Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Tian more than expected).
Fields of papers citing papers by Jing Tian
This network shows the impact of papers produced by Jing Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Tian. The network helps show where Jing Tian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jing Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 23 | |
| 3 | RSF-1 siRNA Enhances Tumor Radiosensitivity in Cervical Cancer via Enhanced DNA Damage, Cell Cycle Redistribution, and Promotion of Apoptosis | 2020 | 1 |
| 4 | 2020 | 9 | |
| 5 | 2020 | 5 | |
| 6 | 2020 | 10 | |
| 7 | 2019 | 10 | |
| 8 | 2019 | 137 | |
| 9 | 2019 | 14 | |
| 10 | Cloning and expression analysis of promoter of CESA7 gene in Betula platyphylla. | 2018 | 1 |
| 11 | 2018 | 9 | |
| 12 | 2016 | 5 | |
| 13 | [Research on the association between U2-dependent spliceosome gene and hepatocellular cancer]. | 2015 | 1 |
| 14 | 2015 | 44 | |
| 15 | 2014 | 26 | |
| 16 | 2014 | 35 | |
| 17 | 2013 | 45 | |
| 18 | 2012 | 4 | |
| 19 | 2010 | 7 | |
| 20 | 2004 | 56 |
About Jing Tian
Jing Tian is a scholar working on Cancer Research, Clinical Biochemistry and Molecular Biology, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (16 papers), MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (8 papers), RNA Research and Splicing (7 papers), Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (5 papers), Advanced Glycation End Products research (4 papers) and Magnetic Bearings and Levitation Dynamics (3 papers). The work is most often cited by research in Cancer Research (498 citations), Physiology (52 citations) and Molecular Biology (751 citations). Jing Tian has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Quan Hao, Xin Fu, Ying Chen, Lei Zhang, Chang Zou, Yutong Wang, Bo Zhu, Yin Kwan Wong, Zhen Liang and Jigang Wang. Their work appears in journals such as OncoTargets and Therapy, Oncotarget, Oncology Reports, Tumor Biology and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.